Literature DB >> 7620031

Group A streptococcus bacteremia at the Hadassah Medical Center in Jerusalem.

A E Moses1, D Mevorach, G Rahav, T Sacks, A Simhon, M Shapiro.   

Abstract

Streptococcus pyogenes bacteremia occurred in 104 patients over a 6-year period, during which time the annual incidence remained constant. The clinical and epidemiologic characteristics are described for 90 of these patients. Of the 90 patients, 90% had community-acquired infection, and 77% had an underlying illness predisposing them to infection. Skin infection was the cause of bacteremia in 61% of the cases. Septic shock developed in 13 patients. The overall mortality rate was 15%. An increased likelihood of death was associated with septic shock and diabetes mellitus.

Entities:  

Mesh:

Year:  1995        PMID: 7620031     DOI: 10.1093/clinids/20.5.1393

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

1.  Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel.

Authors:  I Weiss; Z Gorodnitzky; Z Korenman; P Yagupsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

2.  Invasive group a streptococcal infections, Israel.

Authors:  Allon E Moses; Sara Goldberg; Zinaida Korenman; Miriam Ravins; Emanuel Hanski; Mervyn Shapiro
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

3.  Group G streptococcal bacteremia in Jerusalem.

Authors:  Ronit Cohen-Poradosu; Joseph Jaffe; David Lavi; Sigal Grisariu-Greenzaid; Ran Nir-Paz; Lea Valinsky; Mary Dan-Goor; Colin Block; Bernard Beall; Allon E Moses
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

4.  Group A Streptococcal Bacteremia: Ten Years' Experience from a Tertiary Care Center in South India.

Authors:  Jeethu Sreekala Jayakumar; Vettakkara Kandy Muhammed Niyas; Rajalakshmi Arjun
Journal:  Indian J Crit Care Med       Date:  2022-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.